Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Mizuho Reinstates Buy on Healthpeak Properties, Announces $22 Price Target

Author: Benzinga Newsdesk | April 22, 2024 07:07am
Mizuho analyst Omotayo Okusanya reinstates Healthpeak Properties (NYSE:DOC) with a Buy and announces $22 price target.

Posted In: DOC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist